Julie R. Nangia, MD
Baylor College of Medicine, Houston, TXAuthored Items
October 18, 2017 | Best Practices in Breast Cancer – October 2017 Vol 8
Scalp cooling devices that allow patients treated with chemotherapy to retain their hair are used more commonly in Europe than in the United States, but this may be about to change now that the FDA has approved 2 scalp cooling devices: the DigniCap (approved in 2015) and the Paxman scalp cooling device (approved in 2017).
Last modified: June 9, 2018